Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Find Stocks Tailored to Your Trading Interests

benzingaproreview-1-1280x720

acf/call-to-action

<p class="has-text-align-left"><strong><a href="https://share.hsforms.com/1kQ-soZmmTRqplsRXp5Zfpw1npzh">Claim Exclusive Offers</a></strong></p>





<p></p>

Compare Investing Brokers (USE THIS ONE)

acf/widget-container

acf/compare-products

IBKR Stocks

public.com

Robinhood

TradeZero

eToro Stocks

<p><strong><a href="https://share.hsforms.com/1kQ-soZmmTRqplsRXp5Zfpw1npzh">Claim Exclusive Offers</a></strong></p>





<p></p>

Compare Crypto Brokers Homepage

Plus500 Crypto

Kraken

Webull Crypto

FxGlory

eToro

Uphold Crypto

Compare Brokers Table – Benzinga.com

Cemex

Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.

Anthony Codling's

Wells Fargo ATM

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.</p>



<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/66433a0c6d48530001dc96e5/anthony-codling">RBC Capital analyst Anthony Codling</a> upgraded the rating for <strong>CEMEX, S.A.B. de C.V.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) from Underperform to Sector Perform but lowered the price target from $9 to $6.5. Cemex shares fell 0.7% to close at $5.88 on Monday. <a href="https://www.benzinga.com/quote/CX/analyst-ratings">See how other analysts view this stock</a>.</li>



<li>Wolfe Research analyst Steven Chubak upgraded <strong>Wells Fargo &amp; Company</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) from Peer Perform to Outperform and announced a $65 price target. Wells Fargo shares gained 0.4% to close at $57.16 on Monday. <a href="https://www.benzinga.com/quote/WFC/analyst-ratings">See how other analysts view this stock</a>.</li>



<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59d7dc9c6ab1240001d3a462/vernon-bernardino">HC Wainwright &amp; Co. analyst Vernon Bernardino</a> upgraded the rating for <strong>Cassava Sciences, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>) from Neutral to Buy and announced a price target of $116. Cassava Sciences shares fell 6.2% to close at $25.41 on Monday. <a href="https://www.benzinga.com/quote/SAVA/analyst-ratings">See how other analysts view this stock</a>.</li>



<li>BTIG analyst Vincent Caintic upgraded <strong>Affirm Holdings, Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) from Neutral to Buy and announced a $68 price target. Affirm shares closed at $38.60 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>



<li>Wedbush analyst Jay McCanless upgraded the rating for <strong>UFP Industries, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UFPI#NASDAQ">UFPI</a>) from Neutral to Outperform and raised the price target from $120 to $155. UFP Industries shares closed at $129.58 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>



<p><strong>Considering buying WFC stock? Here&#8217;s what analysts think:</strong> </p>



<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="519" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08090857/image-52-1024x519.png" alt="" class="wp-image-585560" style="width:602px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08090857/image-52-1024x519.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08090857/image-52-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08090857/image-52-768x389.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08090857/image-52.png 1342w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<p>R<strong>ead More: </strong></p>



<ul>
<li><strong><a href="https://www.benzinga.com/news/earnings/24/10/41221716/dow-dips-around-400-points-as-treasury-yields-top-4-investor-optimism-declines-but-fear-index-remai">Dow Dips Around 400 Points As Treasury Yields Top 4%: Investor Optimism Declines, But Fear Index Remains In &#8216;Greed&#8217; Zone</a></strong></li>
</ul>

News

Upgrades

Markets

Analyst Ratings

Trading Ideas

AFRM

BCAX

FXNC

SAVA

UFPI

This Wells Fargo Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

nasdaq shutter

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.</p>



<ul>
<li>Piper Sandler raised <strong>Nasdaq, Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) price target from $73 to $80. Piper Sandler analyst Richard Repetto maintained an Overweight rating. Nasdaq shares fell 1.7% to close at $70.87 on Monday. <a href="https://www.benzinga.com/quote/NDAQ/analyst-ratings">See how other analysts view this stock.</a></li>



<li>HC Wainwright &amp; Co raised the price target for <strong>Scholar Rock Holding Corporation</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRRK#NASDAQ">SRRK</a>) from $30 to $35. HC Wainwright &amp; Co. analyst Andres Maldonado maintained a Buy rating. Scholar Rock shares jumped 362% to close at $34.28 on Monday. <a href="https://www.benzinga.com/quote/SRRK/analyst-ratings">See how other analysts view this stock.</a></li>



<li>TD Cowen cut the price target for <strong>Frontier Communications Parent, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FYBR#NASDAQ">FYBR</a>) from $39 to $38.5. TD Cowen analyst Gregory Williams downgraded the stock from Buy to Hold. Frontier Communications Parent shares fell 0.1% to close at $35.32 on Monday. <a href="https://www.benzinga.com/quote/FYBR/analyst-ratings">See how other analysts view this stock</a>.</li>



<li>RBC Capital cut <strong>CEMEX, S.A.B. de C.V.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) price target from $9 to $6.5. RBC Capital analyst Anthony Codling upgraded the stock from Underperform to Sector Perform. CEMEX shares fell 0.7% to close at $5.88 on Monday. <a href="https://www.benzinga.com/quote/CX/analyst-ratings">See how other analysts view this stock</a>.</li>



<li>Baird boosted <strong>Guidewire Software, Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) price target from $175 to $204. Baird analyst Joe Vruwink maintained an Outperform rating. Guidewire Software shares fell 1.1% to close at $182.17 on Monday. <a href="https://www.benzinga.com/quote/GWRE/analyst-ratings">See how other analysts view this stock.</a></li>



<li>B of A Securities slashed <strong>First Solar, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) price target from $343 to $321. B of A Securities analyst Julien Dumoulin-Smith maintained a Buy rating. First Solar shares fell 0.7% to close at $229.62 on Monday. <a href="https://www.benzinga.com/quote/FSLR/analyst-ratings">See how other analysts view this stock</a>.</li>



<li>Morgan Stanley cut the price target for <strong>SolarEdge Technologies, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) from $28 to $23. Morgan Stanley analyst Andrew Percoco maintained an Equal-Weight rating. SolarEdge rose 1.4% to close at $20.42 on Monday. <a href="https://www.benzinga.com/quote/SEDG/analyst-ratings">See how other analysts view this stock</a>.</li>



<li>Keybanc raised <strong>Tetra Tech, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTEK#NASDAQ">TTEK</a>) price target from $49 to $56. Keybanc analyst Sangita Jain maintained an Overweight rating. Tetra Tech shares fell 0.7% to close at $48.01 on Monday. <a href="https://www.benzinga.com/quote/TTEK/analyst-ratings">See how other analysts view this stock</a>.</li>



<li>Piper Sandler raised the price target for <strong>Phillips 66</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>) from $136 to $144. Piper Sandler analyst Ryan Todd maintained an Overweight rating. Phillips 66 shares fell 0.1% to close at $138.50 on Monday. <a href="https://www.benzinga.com/quote/PSX/analyst-ratings">See how other analysts view this stock</a>.</li>



<li>Stifel boosted <strong>HubSpot, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBS#NYSE">HUBS</a>) price target from $600 to $625. Stifel analyst Parker Lane maintained a Buy rating. HubSpot shares fell 2.4% to close at $522.09 on Monday. <a href="https://www.benzinga.com/quote/HUBS/analyst-ratings">See how other analysts view this stock</a>. </li>
</ul>



<p><strong>Considering buying NDAQ stock? Here&#8217;s what analysts think:</strong> </p>



<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="509" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08080221/image-49-1024x509.png" alt="" class="wp-image-585403" style="width:841px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08080221/image-49-1024x509.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08080221/image-49-300x149.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08080221/image-49-768x381.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08080221/image-49.png 1373w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<p><strong>Read Next: </strong></p>



<ul>
<li><strong><a href="https://www.benzinga.com/news/earnings/24/10/41221716/dow-dips-around-400-points-as-treasury-yields-top-4-investor-optimism-declines-but-fear-index-remai">Dow Dips Around 400 Points As Treasury Yields Top 4%: Investor Optimism Declines, But Fear Index Remains In &#8216;Greed&#8217; Zone</a></strong></li>
</ul>

Price Target

Pre-Market Outlook

FSLR

FYBR

GWRE

HUBS

NDAQ

SEDG

SRRK

TTEK

Nasdaq To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday

analyst ratings image

<p>In the last three months, 5 analysts have published ratings on CRH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRH#NYSE">CRH</a>), offering a diverse range of perspectives from bullish to bearish.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>

<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $95.0, a high estimate of $110.00, and a low estimate of $82.00. Marking an increase of 8.78%, the current average surpasses the previous average price target of $87.33. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1720530043_0.png" alt="price target chart" /></p>

<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>The standing of CRH among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Cedar Ekblom</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$88.00</td>
<td>$87.00</td>
</tr>
<tr>
<td>Trey Grooms</td>
<td>Stephens &amp; Co.</td>
<td>Announces</td>
<td>Overweight</td>
<td>$95.00</td>
<td>-</td>
</tr>
<tr>
<td>Anthony Codling</td>
<td>RBC Capital</td>
<td>Announces</td>
<td>Outperform</td>
<td>$110.00</td>
<td>-</td>
</tr>
<tr>
<td>Keith Hughes</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$100.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Tobias Woerner</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$82.00</td>
<td>$80.00</td>
</tr>
</tbody>
</table>

<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to CRH. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of CRH compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of CRH's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of CRH's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CRH/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on CRH analyst ratings.</strong></a></p>
<h2>Discovering CRH: A Closer Look</h2>
<p>CRH is a global manufacturer of a range of building products used in construction projects, operating via a vertically integrated business model. The past decade has seen CRH transform into a leading building materials business, with increasing exposure to upstream building activities such as aggregates and cement. CRH's geographic footprint is mostly across developed markets. North America is CRH's largest market and accounts for 75% of EBITDA. The company is the largest producer of aggregates and asphalt in the US.</p>
<h3>CRH: Financial Performance Dissected</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.</p>
<p><strong>Revenue Growth:</strong> CRH displayed positive results in 3 months. As of 31 March, 2024, the company achieved a solid revenue growth rate of approximately <strong>1.65%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.</p>
<p><strong>Net Margin:</strong> CRH's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>1.78%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> CRH's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>0.57%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> CRH's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of <strong>0.25%,</strong> the company may face hurdles in generating optimal returns from its assets.</p>
<p><strong>Debt Management:</strong> The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of <strong>0.7</strong>, caution is advised due to increased financial risk.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>

Critical Insights From CRH Analyst Ratings: What You Need To Know

<p>6 analysts have expressed a variety of opinions on CRH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRH#NYSE">CRH</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.</p>
<p>Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>

<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $99.67, a high estimate of $110.00, and a low estimate of $82.00. Witnessing a positive shift, the current average has risen by 8.34% from the previous average price target of $92.00.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1718712078_0.png" alt="price target chart" /></p>

<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>The analysis of recent analyst actions sheds light on the perception of CRH by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Trey Grooms</td>
<td>Stephens &amp; Co.</td>
<td>Announces</td>
<td>Overweight</td>
<td>$95.00</td>
<td>-</td>
</tr>
<tr>
<td>Anthony Codling</td>
<td>RBC Capital</td>
<td>Announces</td>
<td>Outperform</td>
<td>$110.00</td>
<td>-</td>
</tr>
<tr>
<td>Keith Hughes</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$100.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Tobias Woerner</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$82.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Anthony Pettinari</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$106.00</td>
<td>$101.00</td>
</tr>
<tr>
<td>Michael Dudas</td>
<td>Vertical Research</td>
<td>Announces</td>
<td>Buy</td>
<td>$105.00</td>
<td>-</td>
</tr>
</tbody>
</table>

<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to CRH. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of CRH compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of CRH's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of CRH's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CRH/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on CRH analyst ratings.</strong></a></p>
<h2>Discovering CRH: A Closer Look</h2>
<p>CRH is a global manufacturer of a range of building products used in construction projects, operating via a vertically integrated business model. The past decade has seen CRH transform into a leading building materials business, with increasing exposure to upstream building activities such as aggregates and cement. CRH's geographic footprint is mostly across developed markets. North America is CRH's largest market and accounts for 75% of EBITDA. The company is the largest producer of aggregates and asphalt in the US.</p>
<h3>A Deep Dive into CRH's Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.</p>
<p><strong>Revenue Growth:</strong> CRH's remarkable performance in 3 months is evident. As of 31 March, 2024, the company achieved an impressive revenue growth rate of <strong>1.65%</strong>. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Materials sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> CRH's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of <strong>1.78%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> CRH's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>0.57%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> CRH's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>0.25%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> CRH's debt-to-equity ratio is notably higher than the industry average. With a ratio of <b>0.7</b>, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>

Analyst Ratings For CRH

<p>7 analysts have shared their evaluations of CRH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRH#NYSE">CRH</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.</p>
<p>Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>

<p>In the assessment of 12-month price targets, analysts unveil insights for CRH, presenting an average target of $99.71, a high estimate of $110.00, and a low estimate of $82.00. Surpassing the previous average price target of $89.34, the current average has increased by 11.61%.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1715691676_0.png" alt="price target chart" /></p>

<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>The perception of CRH by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Anthony Codling</td>
<td>RBC Capital</td>
<td>Announces</td>
<td>Outperform</td>
<td>$110.00</td>
<td>-</td>
</tr>
<tr>
<td>Keith Hughes</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$100.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Tobias Woerner</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$82.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Anthony Pettinari</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$106.00</td>
<td>$101.00</td>
</tr>
<tr>
<td>Michael Dudas</td>
<td>Vertical Research</td>
<td>Announces</td>
<td>Buy</td>
<td>$105.00</td>
<td>-</td>
</tr>
<tr>
<td>Keith Hughes</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$95.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Justin Jordan</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$100.00</td>
<td>$89.70</td>
</tr>
</tbody>
</table>

<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to CRH. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of CRH compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of CRH's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>For valuable insights into CRH's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CRH/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on CRH analyst ratings.</strong></a></p>
<h2>Get to Know CRH Better</h2>
<p>CRH is a global manufacturer of a range of building products used in construction projects, operating via a vertically integrated business model. The past decade has seen CRH transform into a leading building materials business, with increasing exposure to upstream building activities such as aggregates and cement. CRH's geographic footprint is mostly across developed markets. North America is CRH's largest market and accounts for 75% of EBITDA. The company is the largest producer of aggregates and asphalt in the US.</p>
<h3>A Deep Dive into CRH's Financials</h3>
<p><strong>Market Capitalization:</strong> Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.</p>
<p><strong>Positive Revenue Trend:</strong> Examining CRH's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>1.65%</strong> as of 31 March, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Materials sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of <strong>1.78%,</strong> the company may need to address challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> CRH's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of <strong>0.57%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Return on Assets (ROA):</strong> CRH's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>0.25%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> CRH's debt-to-equity ratio is notably higher than the industry average. With a ratio of <b>0.7</b>, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>

Decoding 7 Analyst Evaluations For CRH

By 10:38 pm, the Dow Jones Industrial Average was up 60.47 points, or 0.59%, to 10,380.57, while the broader Standard & Poor's 500 index had gained 6.95 points, or 0.64%. The NASDAQ composite index rose 17.07 points, or 0.78%. 

Some of the narrow based indexes that are driving the market are Optical Networking Stocks, which have gained 6.6%, Staff, Emplyment, Recruiting, and HR Services Stocks, up 3.0%, and Ireland Stocks and ADRs, moving 2.4% higher as a group.

In Tickerspy's <a href="http://www.tickerspy.com/index/Optical-Networking-Stocks"> Optical Networking </a> complex, Finisar Corporation (NASDAQ: <a class="ticker" href="/stock/fnsr#NASDAQ">FNSR</a>) had surged 15.4%. FNSR had posted upbeat results for its fiscal first quarter.

The best performing Tickerspy <a href="http://www.tickerspy.com/index/Staff,-Emplyment,-Recruiting,-and-HR-Services-Stocks"> Staff, Emplyment, Recruiting, and HR Services </a> stock has been Hudson Highland Group Inc (NASDAQ: <a class="ticker" href="/stock/hhgp#NASDAQ">HHGP</a>), which was up 8.8%. HHGP’s shares have lost 18.18% over the past 52 weeks, while the S&P 500 index has gained 8.66% in the same period.

CRH Plc (NYSE: <a class="ticker" href="/stock/crh#NYSE">CRH</a>) is today’s leading Tickerspy's <a href="http://www.tickerspy.com/index/Ireland-Stocks-and-ADRs"> Ireland Stocks and ADRs </a> stock, gaining 4.2%. JP Morgan analyst Anthony Codling upgraded CRH from “underperform” to “neutral.” 

Read more <a href="http://www.benzinga.com/markets/company-news">from Benzinga's Company news.</a>


Long Ideas

Intraday Update

Movers

FNSR

HHGP

Top Narrow Based Indexes For September 3 (FNSR, HHGP, CRH)

Analyst Ratings Newsletter

Don't Miss Your Daily Analyst Rating Email!!!

acf/newsletter-subscription-box

acf/raptive-ad-placement

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Anthony Codling's Stock Ratings

RBC Capital Analyst

Overall Average Return

Smart Score

Overall Average Return Percentile

Number of Ratings

Recent Analyst Stock Rating News